Skip to main content

Market Overview

Revance Therapeutics (NASDAQ:RVNC) Press Releases

Wednesday, February 24, 2021

Revance to Participate in Upcoming Virtual Healthcare Conferences (RVNC, Press Releases / Wed, 04:05pm)
Worldwide Facial Injectable Industry to 2025 - by Type, Generation, End-user and Geography (AGN, RVNC, Analyst Ratings, Press Releases / Wed, 05:13am)

Tuesday, February 23, 2021

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Tue, 04:05pm)
Ambrx Appoints Audit Executive Chris Nolet to Board of Directors (PTE, RVNC, VIE, Press Releases / Tue, 04:05pm)

Monday, February 22, 2021

Friday, February 12, 2021

Revance to Release Fourth Quarter and Full Year 2020 Financial Results on Monday, February 22, 2021 (RVNC, Press Releases / Fri, 08:00am)

Monday, January 25, 2021

Revance to Highlight Aesthetic Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Study Results at Maui Derm for Dermatologists 2021 (RVNC, Press Releases / Mon, 08:00am)

Friday, January 22, 2021

Revance Issues Inaugural Environmental, Social and Governance (ESG) Report (RVNC, Press Releases / Fri, 08:00am)

Tuesday, January 19, 2021

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Tue, 04:05pm)

Thursday, January 07, 2021

Revance to Participate in the 39th Annual J.P. Morgan Healthcare Conference (RVNC, Press Releases / Thu, 04:05pm)
Revance Provides Corporate Update and Anticipated Milestones for 2021 (RVNC, Press Releases / Thu, 08:00am)

Tuesday, December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection (News, RVNC, Contracts, Press Releases / Tue, 08:00am)

Monday, December 21, 2020

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Mon, 04:05pm)

Thursday, December 17, 2020

Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study (RVNC, Retail Sales, Press Releases / Thu, 08:05am)

Wednesday, December 16, 2020

Governor Lee, Commissioner Rolfe Announce Revance Therapeutics to Relocate Global Headquarters to Nashville (RVNC, Press Releases / Wed, 08:30am)

Wednesday, November 25, 2020

FDA Defers Approval of DaxibotulinumtoxinA for Injection in Glabellar Lines Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspection (RVNC, Press Releases / Wed, 08:30am)

Tuesday, November 24, 2020

Revance to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference (RVNC, Press Releases / Tue, 04:05pm)

Friday, November 20, 2020

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Fri, 04:05pm)

Tuesday, November 10, 2020

Revance to Participate in the Stifel 2020 Virtual Healthcare Conference (RVNC, Press Releases / Tue, 04:05pm)

Monday, November 09, 2020

Revance Announces Results of Phase 2 Trial of DaxibotulinumtoxinA for Injection in Plantar Fasciitis (RVNC, Retail Sales, Press Releases / Mon, 04:05pm)
Revance Reports Third Quarter 2020 Financial Results and Provides Corporate Update (RVNC, Retail Sales, Press Releases / Mon, 04:05pm)
Revance Therapeutics, Inc. to Host Earnings Call (Earnings, News, RVNC, Press Releases / Mon, 02:45pm)

Tuesday, November 03, 2020

Revance to Participate in the Credit Suisse 29th Annual Healthcare Conference (RVNC, Press Releases / Tue, 04:05pm)

Monday, November 02, 2020

Revance to Release Third Quarter 2020 Financial Results on Monday, November 9, 2020 (RVNC, Press Releases / Mon, 04:05pm)

Friday, October 23, 2020

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Fri, 03:05pm)

Wednesday, October 14, 2020

Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia (RVNC, Retail Sales, Press Releases / Wed, 07:00am)

Tuesday, October 06, 2020

Revance to Present Three New Abstracts Evaluating DaxibotulinumtoxinA for Injection and Two ePosters Evaluating the RHA® Collection During the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting (RVNC, Retail Sales, Press Releases / Tue, 07:00am)

Wednesday, September 23, 2020

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (RVNC, Press Releases / Wed, 03:05pm)

Tuesday, September 08, 2020

Revance to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference (RVNC, Press Releases / Tue, 03:05pm)

Wednesday, September 02, 2020

Revance to Participate in the Wells Fargo Securities Healthcare Conference (RVNC, Press Releases / Wed, 07:00am)

Tuesday, August 25, 2020

Revance Commercial Infrastructure Established and Positioned to Launch Prestige Aesthetics Portfolio with the RHA® Collection of Dermal Fillers (RVNC, Retail Sales, Press Releases / Tue, 07:00am)

Tuesday, August 11, 2020

Revance Announces Two Peer-Reviewed Publications Reporting Safety and Efficacy Results from the SAKURA 3 Open-Label Safety Study in Dermatologic Surgery (RVNC, Retail Sales, Press Releases / Tue, 07:30am)

Thursday, August 06, 2020

Revance Reports Second Quarter 2020 Financial Results, Provides Corporate Update (RVNC, Retail Sales, Press Releases / Thu, 03:05pm)

1	AAPL, PLTR: Cathie Wood's Ark Invest Added Shares Of Palantir, Twitter, And S...
2	HLXW, PDPR: SEC Suspends Trading In 15 Stocks Over Social Media Concerns
3	TERN, EYPT: The Week Ahead In Biotech (Feb. 28-March 6): KemPh...
4	XPEV, TSLA: Xpeng To Release New P7 Sedan With Lithi...
5	BAC, BRK-B: Warren Buffett In Annual Lette...
6	FUSE, NFLX: 'SPACS Attack&#...
7	$BTC, TSLA: Coinbase I...

1	MCD, NFLX: Looking Back On Pokemon's 25th Anniversary: Trading Cards, Video G...
2	OSCR, INNV: IPO Outlook: Oscar Health And InnovAge Hit Markets This Week
3	SPY, DIA: Senate To Begin Deliberations This Week On Latest COV...
4	WMT, GS: Walmart Hires 2 Goldman Sachs Bankers To Lead...
5	HTZGQ, GME: When You Buy A Stock, Here's Ho...
6	AAPL: Tony Zhang's Apple Trade
7	SNE, FB: Judge Approves 'Land...